Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

Recruiting

• Conditions: Lymphoma, Non-Hodgkin; Hodgkin's Disease

• Registration Number: NCT00398177
• Lead Sponsor: Stanford University

Brief Summary

The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.

Detailed Description

This research involves the study of lymphoma cells in order to better understand how the disease grows and spreads. This study may lead to the development of special materials that could be used, in the future, to treat lymphoma or to follow the response of lymphoma to treatment.

Study Timeline

• Study Start: 1999-01
• Study First Submitted: 2006-11-09
• Study First Submitted QC: 2006-11-09
• Study First Posted: 2006-11-10
• Status Verified: 2024-12
• Last Update Submitted: 2024-12-17
• Last Update Posted: 2024-12-18
• Primary Completion: 2099-01
• Study Completion: 2099-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 9999

Inclusion Criteria

• Diagnosis of Hodgkin's disease or non-Hodgkin's lymphoma, any cellular classification, any stage, any grade.
• Adult or pediatric patients receiving lymph node excision for purposes other than cancer therapy (i.e. tonsillectomy, sleep apnea).
• A routine procedure for tissue collection is planned.
• Ability to understand and the willingness to sign a written informed consent.

Exclusion Criteria

• Patients without NHL or Hodgkin's disease

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Collection of tumor tissue to characterize the molecular and cell biology of tumor cells in lymphoma.	The study will continue indefinitely.

Trial Locations

Locations (1)

Stanford University School of Medicine; 🇺🇸 Stanford, California, United States